Rezolute, Inc.
RZLT · Pharmaceutical Preparations · 96.3M shares · +89%/yr ↑ dilution · EDGAR filings ↗
Net buyback after stock comp: -$7M (gross $3K, SBC $7M)
Reference price $2.85 · est. market cap ~$274M — last insider purchase, 2026-03-30 (estimated from the dated SEC Form 4 price × shares outstanding — not a live quote)
Grade
D46Clinical/early-stage biotech — hypoglycemia clinical, very well-funded.
Strengths
- Liquidity — current ratio 14.4 (89th)
Risks
- Pre-revenue, deep losses — per metrics
- Pre-revenue/clinical-stage — history of losses & need for capital per risk factors
- Binary clinical & funding risk — per 10-K
Notable findings
- Fund exitedNotable fund(s) exited this quarter: VANGUARD GROUP INC
- Chronic dilutionShare count +89%/yr over 3y (dilution, book value/share -84%)
- Strong balance sheetStrong balance sheet — $168M cash & investments
- Notable holderHeld by 5 notable fund(s): STATE STREET CORP, GOLDMAN SACHS GROUP INC, CITADEL ADVISORS LLC +2 more (as of 2026-03-31)
Key metrics
Return on equity
-45.9%
Return on assets
-42.4%
Current ratio
14.4×
EBITDA
-$80M
Tangible book value
$162M
Cash & investments
$168M
Insider transactions · last 18 months
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-03-30 | Evans Daron | Buy | 10K | $2.85 |
| 2026-03-02 | ROBERTS BRIAN KENNETH | Tax withheld | 11K | $2.99 |
| 2026-03-02 | Evans Daron | Tax withheld | 11K | $2.99 |
| 2026-03-02 | Elam Nevan C | Tax withheld | 28K | $2.99 |
| 2025-12-16 | Hogenhuis Wladimir | Buy | 5.7K | $1.69 |
| 2025-12-16 | ROBERTS BRIAN KENNETH | Buy | 28K | $1.70 |
| 2025-12-15 | Evans Daron | Buy | 40K | $1.77 |
| 2025-12-15 | Evans Daron | Buy | 2.5K | $1.78 |
| 2025-12-15 | Evans Daron | Buy | 2.5K | $1.79 |
| 2025-12-15 | Elam Nevan C | Buy | 32K | $1.59 |
| 2025-12-15 | Karnawat Sunil Ratilal | Buy | 12K | $1.62 |
| 2025-12-15 | Karnawat Sunil Ratilal | Buy | 100 | $1.60 |
| 2025-11-19 | ROBERTS BRIAN KENNETH | Grant | 123K | — |
| 2025-11-19 | Karnawat Sunil Ratilal | Grant | 32K | — |
| 2025-11-19 | Elam Nevan C | Grant | 317K | — |
| 2025-11-19 | Evans Daron | Grant | 107K | — |
| 2025-11-19 | KREHER NERISSA | Grant | 21K | — |
| 2025-11-19 | Hogenhuis Wladimir | Grant | 21K | — |
| 2025-11-19 | Harris Erik | Grant | 21K | — |
| 2025-11-19 | Kim Young-Jin | Grant | 21K | — |
| 2025-11-19 | FAUCHET PHILIPPE | Grant | 21K | — |
| 2025-11-19 | Labrucherie Gil M | Grant | 21K | — |
| 2025-08-18 | Karnawat Sunil Ratilal | Grant | 25K | — |
| 2025-06-25 | ROBERTS BRIAN KENNETH | Buy | 2.5K | $4.38 |
| 2025-06-24 | Evans Daron | Buy | 5.0K | $4.05 |
| 2025-06-13 | Kim Young-Jin | Buy | 1.2M | $3.25 |
| 2025-06-13 | KREHER NERISSA | Buy | 3.1K | $3.25 |
| 2025-06-10 | KREHER NERISSA | Grant | 9.0K | — |
| 2025-06-10 | Labrucherie Gil M | Grant | 9.0K | — |
| 2025-06-10 | Hogenhuis Wladimir | Grant | 9.0K | — |
| 2025-06-10 | Kim Young-Jin | Grant | 9.0K | — |
| 2025-06-10 | Evans Daron | Grant | 26K | — |
| 2025-06-10 | FAUCHET PHILIPPE | Grant | 9.0K | — |
| 2025-06-10 | ROBERTS BRIAN KENNETH | Grant | 26K | — |
| 2025-06-10 | Elam Nevan C | Grant | 68K | — |
| 2025-03-31 | Hogenhuis Wladimir | Buy | 6.8K | $2.92 |
| 2025-03-27 | Elam Nevan C | Buy | 12K | $2.85 |
| 2025-03-26 | Evans Daron | Buy | 10K | $2.88 |
| 2025-03-26 | Evans Daron | Buy | 10K | $2.89 |
| 2025-02-18 | Hogenhuis Wladimir | Buy | 10K | $4.70 |
| 2025-02-16 | Evans Daron | Grant | 77K | — |
| 2025-02-16 | KREHER NERISSA | Grant | 26K | — |
| 2025-02-16 | Kim Young-Jin | Grant | 26K | — |
| 2025-02-16 | ROBERTS BRIAN KENNETH | Grant | 77K | — |
| 2025-02-16 | Elam Nevan C | Grant | 204K | — |
| 2025-02-16 | FAUCHET PHILIPPE | Grant | 26K | — |
| 2025-02-16 | Hogenhuis Wladimir | Grant | 26K | — |
| 2025-02-16 | Labrucherie Gil M | Grant | 26K | — |
All non-derivative Form 4 activity (SEC), newest first.
Notable events (8-K)
Recent filings
| Form | Filed | Period | Accession |
|---|---|---|---|
| 8-K | 2026-06-02 | 2026-06-02 | 0001104659-26-069206 ↗ |
| 8-K | 2026-05-12 | 2026-05-12 | 0001104659-26-059392 ↗ |
| 10-Q | 2026-05-12 | 2026-03-31 | 0001104659-26-059422 ↗ |
| 8-K | 2026-05-04 | 2026-05-01 | 0001104659-26-054943 ↗ |
| 8-K | 2026-03-24 | 2026-03-24 | 0001104659-26-033592 ↗ |
| 10-Q | 2026-02-12 | 2025-12-31 | 0001104659-26-014334 ↗ |
| 8-K | 2026-02-12 | 2026-02-12 | 0001104659-26-014287 ↗ |
| 8-K | 2026-01-07 | 2026-01-07 | 0001104659-26-001556 ↗ |
| 8-K | 2025-11-21 | 2025-11-19 | 0001104659-25-115050 ↗ |
| 8-K | 2025-11-12 | 2025-11-10 | 0001104659-25-109559 ↗ |
| 10-Q | 2025-11-06 | 2025-09-30 | 0001104659-25-107781 ↗ |
| 8-K | 2025-11-06 | 2025-11-06 | 0001104659-25-107743 ↗ |